Table 4.
Mean percent blood glucose reduction in normal rats (N = 6)
|
Time (h) |
Gliclazide | Nevirapine | Nevirapine + Gliclazide*(Single dose treatment) | Nevirapine + Gliclazide*(Multiple dose treatment) |
| 1 | 30.88 ± 1.12 | -01.44 ± 0.46 | 30.43 ± 1.09 | 30.83 ± 0.94 |
| 2 | 40.72 ± 0.56 | 02.88 ± 0.45 | 38.35 ± 0.72 | 40.49 ± 0.84 |
| 3 | 28.34 ± 0.82 | 03.96 ± 0.64 | 26.84 ± 0.79 | 28.30 ± 0.68 |
| 4 | 23.97 ± 0.79 | 04.68 ± 0.65 | 22.90 ± 0.99 | 23.63 ± 1.13 |
| 6 | 30.90 ± 0.46 | 02.51 ± 0.66 | 30.42 ± 1.00 | 31.53 ± 0.67 |
| 8 | 37.46 ± 1.18 | 01.43 ± 0.71 | 35.14 ± 1.23 | 37.62 ± 1.44 |
| 10 | 24.73 ± 0.69 | 01.05 ± 1.66 | 23.61 ± 1.01 | 25.81 ± 0.76 |
| 12 | 10.52 ± 1.14 | 00.34 ± 1.40 | 10.33 ± 1.30 | 11.80 ± 1.16 |
*Statistically no significance compared to gliclazide control